NEW YORK (GenomeWeb) – LifeCodexx and Sengenics have partnered to offer LifeCodexx's noninvasive prenatal fetal trisomy PrenaTest in Southeast Asia.

Under the agreement, the PrenaTest will be available to women in Malaysia, Singapore, Thailand, Brunei, Vietnam, the United Arab Emirates, and elsewhere in the Middle East.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.